Home›Companies›Healthcare›LifeLens

LifeLens Technologies, Inc.

Makes wearable devices that monitor patients' heart activity and other vital signs.

Updated Nov 9, 2026·Latest SEC filing Sep 8, 2026·Suggest an edit

About LifeLens

LifeLens is a private company based in Ivyland, Pennsylvania. It has reported $45,676,336 raised in five offerings on Form D since July 2019. Its chief executive is Landy Toth.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 4, 2025Nov 17, 2025amended Sep 8, 2026$21,104,217of $40.0M target43$490KEquityRule 506(b)Form D/A ↗1 earlier filing
Jun 28, 2024Jul 15, 2024$18,373,964of $35.0M target41$448KEquityRule 506(b)Form D ↗
Sep 30, 2021Oct 21, 2021$78,160of $15.0M target2$39,080EquityRule 506(b)Form D ↗
Jul 20, 2020Aug 4, 2020$3,199,995of $5.0M target14$228KEquityRule 506(b)Form D ↗
Jun 21, 2019Jul 17, 2019$2,920,000of $4.0M target19$153KDebt, OptionsRule 506(b)Form D ↗
Total, five offerings$45,676,336

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on LifeLens's Form D filed Sep 8, 2026.

BR
Brian Robins
Director
GP
Gunnar Pah
Director
PD
Phil Dilorio
Director
NM
Neil Muchin
Director
HR
LT
Landy Toth
Founder and CEO, director
TJ
Todd Johnson
Director

Earlier filings also listed Robert Schwartz (director, last listed Jul 2024), Rick Buchholz (director, last listed Jul 2024), Neil Munchin (director, last listed Jul 2024) and Daniel Sullivan (executive officer and director, last listed Jul 2024).

Sources

  1. SECLifeLens Technologies, Inc. Form D, filed Nov 17, 2025
  2. SECLifeLens Technologies, Inc. filing history
  3. CompanyVital sign monitoring clearance announcement
  4. PressLifeLens vital sign monitoring clearance release